CJC + Ipamorelin
CJC + Ipamorelin
10 · 20 mg In stock2 strengths available1 unitfrom 45.00 €
3+ unitseachfrom 42.00 €
Tesamorelin
For research use only
Tesamorelin
An analogue of growth hormone-releasing hormone (GHRH). 44 amino acids with a stabilising N-terminal modification, lyophilised powder.
Amount of active substance
1 ks
40.00 €
3+ ksza kus
37.00 €
Total
40.00 €
Dispatch on business days. Lyophilised powder tolerates normal transit times without cooling — storage after delivery is covered in the tab below.
Discreet packaging. Neutral outer packaging with no indication of the contents or the sender.
What Tesamorelin is
- A synthetic analogue of human GHRH with 44 amino acids.
- At the N-terminus it carries a trans-3-hexenoyl group, which protects the molecule from degradation by the DPP-4 enzyme.
- It belongs to the GHRH analogues, not to the ghrelin-type secretagogues.
Documented mechanism
- It acts on GHRH receptors in the pituitary; the literature describes stimulation of the pulsatile release of endogenous growth hormone.
- Unlike administering growth hormone from outside, published work describes it as preserving the physiological pulsatile pattern.
- Secondarily, studies follow the effect on IGF-1 levels.
Areas of research
- The GHRH – GH – IGF-1 axis and its regulation.
- Distribution of visceral fat.
- Lipid metabolism.
State of knowledge
Tesamorelin has a clinical literature, including controlled studies in a narrowly
defined indication. Findings from it apply to an authorised medicine given under
medical supervision and are not transferable to other uses.
Regulatory notice
Tesamorelin is the active substance of an authorised medicine. This item is a
**reference standard intended strictly for laboratory and research use**. It is
not a medicine and must not be used for diagnosis, prevention or treatment.
We provide no dosing or health advice. The purchaser is responsible for
complying with the law in force at the place of delivery.
The efficacy and safety of administering this substance to humans are not sufficiently established clinically. The information given here is solely a summary of published research findings, predominantly from laboratory and animal models. It constitutes neither a health claim nor a recommendation for use in humans. The product is intended strictly for research purposes and is not a medicine.
Handling and documentation
- Name
- Tesamorelin
- Form
- Lyophilised powder
- Category
- Growth hormones and peptides
| Strength | Cat. no. | Batch | Purity | 1 unit | 3+ units |
|---|---|---|---|---|---|
| 5 mg | UP-TESA-5 | batch TS-2407 | 99.02 % | 40 € | 37 € |
| 10 mg | UP-TESA-10 | batch TS-2407 | 99.02 % | 65 € | 63 € |
| 20 mg | UP-TESA-20 | batch TS-2407 | 99.02 % | 87 € | 82 € |
- Solvent
- Bacteriostatic water (Bac Water) — available as a separate item in the Supporting products category.
- Procedure
- Run the solvent down the wall of the vial, not directly onto the lyophilised powder. Do not shake the vial — swirl gently until fully dissolved.
- Note
- We provide no dosing protocols and no recommendations for use in humans. What is given here are laboratory handling procedures only.
- Lyophilised (unreconstituted)
- −20 °C, in the dark, in the original packaging.
- After reconstitution
- 2–8 °C, protected from light. Do not refreeze repeatedly.
- Transport
- Neutral packaging, no cold chain. A short-term rise in temperature during transit has no material effect on the lyophilised powder.
- Batch
- TS-2407
- Purity
- 99.02 %
- Identity
- Confirmed by mass spectrometry
- Document
- Download COA (PDF) →
You save 9.00 € on 3 units.
Related items
Tesamorelin
40.00 €